These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 28847477)

  • 1. Hot Melt Extrudates Formulated Using Design Space: One Simple Process for Both Palatability and Dissolution Rate Improvement.
    Malaquias LFB; Schulte HL; Chaker JA; Karan K; Durig T; Marreto RN; Gratieri T; Gelfuso GM; Cunha-Filho M
    J Pharm Sci; 2018 Jan; 107(1):286-296. PubMed ID: 28847477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach.
    Agrawal A; Dudhedia M; Deng W; Shepard K; Zhong L; Povilaitis E; Zimny E
    AAPS PharmSciTech; 2016 Feb; 17(1):214-32. PubMed ID: 26757898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous production of itraconazole-based solid dispersions by hot melt extrusion: Preformulation, optimization and design space determination.
    Thiry J; Lebrun P; Vinassa C; Adam M; Netchacovitch L; Ziemons E; Hubert P; Krier F; Evrard B
    Int J Pharm; 2016 Dec; 515(1-2):114-124. PubMed ID: 27720874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioavailability enhancement of itraconazole-based solid dispersions produced by hot melt extrusion in the framework of the Three Rs rule.
    Thiry J; Kok MG; Collard L; Frère A; Krier F; Fillet M; Evrard B
    Eur J Pharm Sci; 2017 Mar; 99():1-8. PubMed ID: 27951411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hot-melt extrusion for enhanced delivery of drug particles.
    Miller DA; McConville JT; Yang W; Williams RO; McGinity JW
    J Pharm Sci; 2007 Feb; 96(2):361-76. PubMed ID: 17075869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME.
    Huang S; O'Donnell KP; Keen JM; Rickard MA; McGinity JW; Williams RO
    AAPS PharmSciTech; 2016 Feb; 17(1):106-19. PubMed ID: 26335416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of film-casting technique to investigate drug-polymer miscibility in solid dispersion and hot-melt extrudate.
    Parikh T; Gupta SS; Meena AK; Vitez I; Mahajan N; Serajuddin AT
    J Pharm Sci; 2015 Jul; 104(7):2142-52. PubMed ID: 25917333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of stability-enhanced ternary solid dispersions via combinations of HPMCP and Soluplus
    Albadarin AB; Potter CB; Davis MT; Iqbal J; Korde S; Pagire S; Paradkar A; Walker G
    Int J Pharm; 2017 Oct; 532(1):603-611. PubMed ID: 28923766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five-Stage Approach for a Systematic Screening and Development of Etravirine Amorphous Solid Dispersions by Hot-Melt Extrusion.
    Simões MF; Pereira A; Cardoso S; Cadonau S; Werner K; Pinto RMA; Simões S
    Mol Pharm; 2020 Feb; 17(2):554-568. PubMed ID: 31774685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased dissolution and oral absorption of itraconazole/Soluplus extrudate compared with itraconazole nanosuspension.
    Zhang K; Yu H; Luo Q; Yang S; Lin X; Zhang Y; Tian B; Tang X
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1285-92. PubMed ID: 23562534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel supercritical carbon dioxide impregnation technique for the production of amorphous solid drug dispersions: a comparison to hot melt extrusion.
    Potter C; Tian Y; Walker G; McCoy C; Hornsby P; Donnelly C; Jones DS; Andrews GP
    Mol Pharm; 2015 May; 12(5):1377-90. PubMed ID: 25730138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solubility and bioavailability enhancement study of lopinavir solid dispersion matrixed with a polymeric surfactant - Soluplus.
    Zi P; Zhang C; Ju C; Su Z; Bao Y; Gao J; Sun J; Lu J; Zhang C
    Eur J Pharm Sci; 2019 Jun; 134():233-245. PubMed ID: 31028820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Micro-scale solubility assessments and prediction models for active pharmaceutical ingredients in polymeric matrices.
    Bochmann ES; Neumann D; Gryczke A; Wagner KG
    Eur J Pharm Biopharm; 2019 Aug; 141():111-120. PubMed ID: 31100430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analyzing the impact of different excipients on drug release behavior in hot-melt extrusion formulations using FTIR spectroscopic imaging.
    Pudlas M; Kyeremateng SO; Williams LAM; Kimber JA; van Lishaut H; Kazarian SG; Woehrle GH
    Eur J Pharm Sci; 2015 Jan; 67():21-31. PubMed ID: 25445833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of a suitable in vitro dissolution test for itraconazole-based solid dispersions.
    Thiry J; Broze G; Pestieau A; Tatton AS; Baumans F; Damblon C; Krier F; Evrard B
    Eur J Pharm Sci; 2016 Mar; 85():94-105. PubMed ID: 26850682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of mixtures of polymeric carriers for dissolution enhancement of fenofibrate using hot-melt extrusion.
    Kalivoda A; Fischbach M; Kleinebudde P
    Int J Pharm; 2012 Jun; 429(1-2):58-68. PubMed ID: 22440149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of type and ratio of solubilising polymer on characteristics of hot-melt extruded orodispersible films.
    Low AQ; Parmentier J; Khong YM; Chai CC; Tun TY; Berania JE; Liu X; Gokhale R; Chan SY
    Int J Pharm; 2013 Oct; 455(1-2):138-47. PubMed ID: 23916824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of drug physical state on the dissolution enhancement of solid dispersions prepared via hot-melt extrusion: a case study using olanzapine.
    Pina MF; Zhao M; Pinto JF; Sousa JJ; Craig DQ
    J Pharm Sci; 2014 Apr; 103(4):1214-23. PubMed ID: 24765654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of composition in the development of carbamazepine hot-melt extruded solid dispersions by application of mixture experimental design.
    Djuris J; Ioannis N; Ibric S; Djuric Z; Kachrimanis K
    J Pharm Pharmacol; 2014 Feb; 66(2):232-43. PubMed ID: 24350884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of spray dried ternary solid dispersions comprising itraconazole, soluplus and HPMCP: Effect of constituent compositions.
    Davis MT; Potter CB; Mohammadpour M; Albadarin AB; Walker GM
    Int J Pharm; 2017 Mar; 519(1-2):365-372. PubMed ID: 28131850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.